Autonomic Neuropathy (nerve inflammation) plays a crucial role in various diseases, yet its detection remains complex and often overlooked in large-scale research and clinical practice.

The Vagus Device™ offers a simple, standardized, and user-friendly method for assessing autonomic function, making screening more efficient and accessible across multiple research fields.

Our approved solution offers cost-effective and patient-centered detection of autonomic neuropathy, enabling early intervention and improved patient outcomes.

Vagus-Examination

Vagus-Examination (.mov)

Autonomic Neuropathy


Broad Clinical Relevance Across Diseases - Autonomic Neuropathy is a frequently overlooked complication that occurs across a wide spectrum of chronic and complex diseases, including:


🔹Diabetes

🔹Parkinson’s disease

🔹Schizophrenia

🔹Rheumatoid arthritis

🔹Lupus

🔹Multiple sclerosis

🔹Severe infectious diseases e.g. COVID-19

🔹Cancer


A unifying feature of these conditions is an increased risk of cardiometabolic disease, often preceded by measurable dysfunction of the vagus nerve. The vagus nerve, responsible for approximately 75% of all parasympathetic nervous system activity, plays a pivotal role in maintaining autonomic balance and systemic health.

Vagus Device customers




Research

Not only within diabetes research but across a broad range of scientific fields, a simple and user-friendly method for detecting autonomic dysfunction can significantly enhance large-scale screening efficiency. Several hospital departments have already integrated Vagus™ into their research, benefiting from its well-defined test protocol, broad clinical acceptance, and strong scientific validation. With more than 40 peer-reviewed publications and adoption in over eight countries, our technology is trusted by leading pharmaceutical companies to refine and optimize drug development. By incorporating a standardized test for autonomic dysfunction and neuropathy, researchers gain critical physiological insights that drive innovation:

🔹 Optimize Participant Selection – Improve study reliability by identifying the most suitable candidates.
🔹 Enhance Drug Development Success – Strengthen safety and efficacy data, streamline regulatory approvals, and accelerate progress toward better patient outcomes.

Technology

The Vagus™ Device is CE Marked and approved for diagnosis of autonomic neuropathy. The underlying technology of Vagus™ is an ECG standard lead I. Vagus™ is a simple hand-held device. The display guides the user through four standard measurements comprising a complete Vagus™ test: Resting, supine to upright position, deep breathing and the Valsalva maneuver. Vagus™ has an integrated manometer to which the external Valsalva equipment can easily be connected. Instead of using standard ECG electrodes, as do traditional devices, this hand-held device applies the palm of the hand as ‘electrode positioning’. This is possible by optimisation of both ECG electrodes and electronics.








Why The Vagus Device Stands Out


🔹 On-Site Testing: Experience the convenience of performing comprehensive autonomic neuropathy tests directly in your clinic. No more delays – get immediate, accurate results for your patients.
🔹 Reliable and Accurate: With a track record of over 20,000 successful patient tests, our device has proven its reliability and accuracy time and time again.
🔹 Global Impact: Used in 8 countries, The Vagus Device is making a difference in the lives of patients worldwide, providing top-notch diagnostics wherever it goes.
🔹 Easy Integration: Designed for seamless integration into any medical practice, The Vagus Device is user-friendly and easy to operate, making it a valuable addition to your diagnostic toolkit.
🔹 Cutting-Edge Technology: Stay ahead with the latest in medical innovation. The Vagus Device leverages advanced technology to deliver precise measurements and detailed analysis.


Vagus Device customers
Kontakt – MEDICUS engineering